Log in to save to my catalogue

N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Function...

N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Function...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7691692

N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects

About this item

Full title

N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects

Publisher

New York: Springer US

Journal title

Journal of clinical immunology, 2021-02, Vol.41 (2), p.335-344

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

In 2014, we reported two siblings with a rare congenital disorder of glycosylation due to mutations in mannosyl-oligosaccharide glucosidase (MOGS). The glycan alteration derived from this disease resulted in an in vitro infection resistance to particular enveloped, N-glycosylation-dependent viruses as influenza and HIV. As part of the global effort...

Alternative Titles

Full title

N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7691692

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7691692

Other Identifiers

ISSN

0271-9142,1573-2592

E-ISSN

1573-2592

DOI

10.1007/s10875-020-00905-4

How to access this item